Characterization of Bacterial and Fungal Colonizers of the Oral Cavity among the Human Immunodeficiency Virus (HIV/AIDS) Infected Individuals before and after Initiation of Highly Active Antiretroviral Therapy (HAART)

Padmajakshi. G¹, S. Saini¹ and K V Ramana^2,

¹Department of Microbiology, Pravara Medical College, Loni, Maharashtra, India

²Department of microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India

Cite this paper:
Padmajakshi. G, S. Saini and K V Ramana. Characterization of Bacterial and Fungal Colonizers of the Oral Cavity among the Human Immunodeficiency Virus (HIV/AIDS) Infected Individuals before and after Initiation of Highly Active Antiretroviral Therapy (HAART). American Journal of Infectious Diseases and Microbiology. 2015; 3(4):125-128. doi: 10.12691/ajidm-3-4-1

Abstract

It is a well known fact that human immunodeficiency virus (HIV) infection is a word wide pandemic. HIV and acquired immunodeficiency syndrome (AIDS) with oral infections are among world’s most severe public health threat. HIV infection is associated with risk of developing opportunistic infections and especially contribute to oral infections which are further complicated as most of the infections are due to normal flora/microorganisms of endogenous origin. Therefore, rapid and early detection, isolation and characterization of these oral infections related to oral micro biome enhances knowledge of physicians involved in HIV patient care to control and prevent HIV infected individuals from future complications which could be responsible for severe morbidity and mortality. Asymptomatic carrier detection of potential pathogens is important to control infections and also act as a treatment guide for clinical and epidemiological purposes for both clinicians treating HIV patients and clinical microbiologists. Oral infections in HIV infected patients have become an increasing cause of clinical concern for several reasons: firstly they are associated with adverse clinical outcomes and secondly most of them are asymptomatic carriers. This study is an attempt made by us to determine the prevalence of oral micro biota and their association with opportunistic infections in HIV infected patients before and after initiation of highly active antiretroviral therapy (HAART).

Keywords:
HIV infections Oral micro biota highly active antiretroviral therapy (HAART) opportunistic infections in HIV infection normal bacterial and fungal colonizers of the oral cavity

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	HIV relatedinfections of oral cavity by G. Ficarra. Institutr of Odontology & Stomatology. Italyclin: Reviewin oral biology & med, 3(3):207-231(1992).
[2]	Cedric Mims, Hazel M Dockrell, Richard V Goering, Ivan Roitt, Derek Wakelin and Mark Zuckerman. Medical Microbiology. 3rd edition Chapter 16. Parasite survival strategies and persistent infections. Mosby, Elsevier, spain, p 167, 2004.
[3]	Dedic A, Masic I. Diabees mellitus in candida. Med Arh 199, 53: 43-45.
[4]	Resende MA, Sousa LVNF Oliveira RCBW, Koga Ito CY, Lyon JP. Prevalence & antifungal susceptibiliy of yeasts obained from the oral cavity of elderly individuals. Mycopathologia 2006:162: 39-44.
[5]	Davies AN, Brailsford SR, Beighton D. Oral candidosis in patients with advanced cancer. Oral Oncol 2006:42:698-702
[6]	Bagg J, Sweeney MP, Lewis MAO, Jackson MS, Coleman D,AL Masaid A. High prevalence of non-albicans yeasts & deection of anti-fungal resistance inthe oral flora of patiens with advanced cancer. P alliat Med 2003; 17; 477-81.
[7]	Soll, D.R. Phenotypic switching. In Candida and Candidiasis. Calderone, R.A. (ed.). Washington, DC: American Society for Microbiology Press, pp. 123-142, 2002.
[8]	Winn WC, Allen S, Janda WM, Koneman EW, Schreckenberger PC, Procop G, Baker Woods G., In: Koneman's Color Atlas and Textbook of Diagnostic Micryobiology, 6th ed. Williams and Wilkins, Lippincott.
[9]	Collee JG, Miles RS, Watt B. Tests for identification of bacteria. In Collee JG, Fraser AG, Marmion BP, Simmons A. eds. Mackie and McCartney's Practical medical microbiology, 14th ed. Churchill Livingstone, 2006.
[10]	Odds FC, Candida & Candidosis. London. Bailliere. Tindall; 1988.
[11]	Hazen KC, New emerging yeast pathogens. Clin. Microbio Rev 1995;8:462-78.
[12]	Padmajakshi. G, S. Saini, Sachin deorukhkar, and K V Ramana, “Coagulase Activity of Candida Spp Isolated from HIV Seropositive Patients Using Different Animal Plasma.” American Journal of Microbiological Research, vol. 2, no. 2 (2014): 57-59.
[13]	Nittayananta W, Talungehti s, Jarurantanasirikul s. et al(2010). Effects of longterm use of HAART on oral health status of HIV-infected subjects. J Oral Pathol Med 39: 397-406.
[14]	Patton LL. Progress in understanding oral health and HIV/AIDS. oral diseases 2014; 20 (3): 2223-225.
[15]	Mc Cullough MJ, Savage NW. Oral candidosis & therapeutic use of anifungal agents in dentisry. Aust Dent J 2005;50;36-39.
[16]	Selma Muzuro Vic, Mirsada Hukic et.al. The relationship between cigarate smoking & oral colonizaion with Candida sp’s in healthy adult subjects. Med Glas (zenica) 2013, 10(2) 397-399.
[17]	Moniacin, Cavallari M-36,Greco D, Bruatlo M, Raiteri R, Palomba E, Tovo PA, Sinicco A,Oral lessions in children born to HIV-1 positive women.J oral pathol med (993:22:8-11).
[18]	Pranab K. Mukherjee, jyotsna chandra et.al. Oral microbiome analysis of HIV infected patient’s. Presented at 49th annual meeting infectious diseases, society of USA.Oct 2011.